Profile data is unavailable for this security.
About the company
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
- Revenue in USD (TTM)348.67m
- Net income in USD-22.75m
- Incorporated2001
- Employees766.00
- LocationInogen Inc859 WARD DRIVEGOLETA 93111United StatesUSA
- Phone+1 (805) 562-0500
- Fax+1 (302) 636-5454
- Websitehttps://www.inogen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apyx Medical Inc | 47.90m | -14.54m | 134.53m | 220.00 | -- | 21.21 | -- | 2.81 | -0.3644 | -0.3644 | 1.19 | 0.1546 | 0.8113 | 1.97 | 3.68 | 217,736.40 | -24.60 | -27.67 | -29.90 | -33.35 | 62.65 | 64.81 | -30.32 | -43.61 | 3.61 | -2.04 | 0.8507 | -- | -8.11 | 11.24 | -25.38 | -- | -11.11 | -- |
| Fonar Corp | 106.03m | 7.07m | 135.87m | 535.00 | 17.51 | 0.6872 | 9.47 | 1.28 | 1.06 | 1.06 | 15.91 | 27.01 | 0.4988 | 22.37 | 1.29 | 198,189.40 | 4.55 | 6.77 | 4.57 | 7.19 | 40.80 | 45.46 | 9.13 | 13.74 | 9.81 | -- | 0.0018 | -- | 1.43 | 4.02 | -21.26 | 0.1719 | -12.96 | -- |
| LifeMD Inc | 252.34m | -7.71m | 140.08m | 304.00 | -- | 103.15 | 28.37 | 0.5551 | -0.1711 | -0.1711 | 5.66 | 0.0282 | 3.64 | 10.83 | 33.00 | 830,075.60 | -4.29 | -109.71 | -31.14 | -396.03 | 86.96 | 85.59 | -1.18 | -33.12 | 0.6645 | 0.3164 | 0.00 | -- | 39.27 | 76.32 | 7.23 | -- | -- | -- |
| LENSAR Inc | 59.14m | -51.52m | 143.22m | 140.00 | -- | -- | -- | 2.42 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
| Pro-Dex Inc | 70.23m | 11.19m | 147.89m | 181.00 | 13.76 | 3.62 | 11.89 | 2.11 | 3.35 | 3.35 | 21.03 | 12.73 | 1.18 | 2.65 | 4.40 | 388,016.60 | 18.87 | 12.06 | 23.88 | 15.24 | 28.09 | 29.81 | 15.94 | 11.73 | 2.14 | -- | 0.2418 | 0.00 | 23.68 | 13.84 | 322.10 | 7.99 | 19.14 | -- |
| Edap Tms SA (ADR) | 74.56m | -22.94m | 151.67m | 310.00 | -- | 5.56 | -- | 2.03 | -0.6127 | -0.6127 | 1.99 | 0.7289 | 0.9081 | 2.08 | 3.62 | 240,515.10 | -27.94 | -11.18 | -49.24 | -15.86 | 43.24 | 42.19 | -30.77 | -16.63 | 0.9729 | -- | 0.2062 | -- | 6.11 | 7.38 | 10.20 | -- | 55.92 | -- |
| Citrine Global Corp | 0.00 | -1.74m | 162.79m | 18.00 | -- | -- | -- | -- | -0.0016 | -0.0016 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -118.80 | -238.43 | -- | -- | -- | -- | -- | -186,483.40 | -- | -2.10 | -- | -- | -- | -- | 25.99 | -- | -- | -- |
| Inogen Inc | 348.67m | -22.75m | 168.30m | 766.00 | -- | 0.8728 | -- | 0.4827 | -0.8571 | -0.8571 | 13.11 | 7.08 | 1.17 | 7.66 | 10.19 | -- | -7.65 | -13.24 | -10.01 | -16.09 | 44.24 | 44.13 | -6.52 | -14.48 | 2.71 | -- | -- | -- | 3.86 | 2.48 | 36.62 | -- | -10.01 | -- |
| Nano-X Imaging Ltd | 12.30m | -55.71m | 170.26m | 165.00 | -- | 1.03 | -- | 13.84 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Acme United Corp | 194.96m | 10.02m | 170.43m | 633.00 | 18.39 | 1.47 | 10.49 | 0.8742 | 2.43 | 2.43 | 47.35 | 30.41 | 1.15 | 2.03 | 6.35 | 307,993.70 | 5.92 | 7.26 | 6.81 | 8.54 | 39.51 | 36.34 | 5.14 | 5.68 | 1.75 | 8.57 | 0.1962 | 18.40 | 1.56 | 6.42 | -43.67 | 12.70 | 33.59 | 4.56 |
| Accendra Health Inc | 4.72bn | -123.85m | 179.63m | 6.50k | -- | -- | 1.37 | 0.038 | -1.61 | -14.30 | 61.33 | -6.03 | 1.33 | 45.41 | 30.05 | 726,184.00 | -3.48 | -0.9299 | -5.75 | -1.46 | 31.70 | 25.69 | -2.62 | -0.723 | 0.4999 | 1.08 | 1.29 | -- | 3.06 | -20.10 | 70.72 | -- | 27.74 | -- |
| InfuSystem Holdings Inc | 143.44m | 6.63m | 187.80m | 502.00 | 29.46 | 3.28 | 9.41 | 1.31 | 0.3153 | 0.3153 | 6.81 | 2.84 | 1.41 | 10.59 | 6.51 | -- | 6.49 | 2.25 | 7.97 | 2.69 | 55.98 | 54.61 | 4.62 | 1.83 | 1.53 | 9.37 | 0.255 | -- | 6.36 | 8.05 | 182.60 | -17.49 | -12.48 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 189.84m | 72.00 | -- | -- | -- | 43.16 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
| Rapid Micro Biosystems Inc | 30.52m | -44.29m | 195.02m | 163.00 | -- | 4.40 | -- | 6.39 | -0.9984 | -0.9984 | 0.6884 | 1.00 | 0.3209 | 1.33 | 6.40 | 187,257.70 | -46.56 | -38.13 | -56.14 | -43.36 | 7.72 | -27.98 | -145.11 | -253.02 | 2.95 | -- | 0.3003 | -- | 24.57 | 11.18 | 10.63 | -- | -4.24 | -- |
| Electromed Inc | 68.86m | 8.99m | 199.44m | 177.00 | 23.46 | 4.39 | 19.57 | 2.90 | 1.03 | 1.03 | 7.86 | 5.49 | 1.28 | 4.59 | 2.69 | 389,045.20 | 16.78 | 9.33 | 20.17 | 11.04 | 78.23 | 76.56 | 13.06 | 8.40 | 4.49 | -- | 0.00 | 0.00 | 16.97 | 14.53 | 46.35 | 12.62 | -20.72 | -- |
| SANUWAVE Health Inc | 41.28m | -7.04m | 206.34m | 46.00 | -- | -- | -- | 5.00 | -0.9346 | -0.9346 | 4.68 | -0.3418 | 1.44 | 1.75 | 11.07 | 897,456.50 | -24.53 | -124.81 | -- | -- | 78.26 | 71.67 | -17.06 | -144.71 | 0.808 | 0.0999 | 1.14 | -- | 59.99 | 99.65 | -21.56 | -- | 55.47 | -- |
Data as of Mar 03 2026. Currency figures normalised to Inogen Inc's reporting currency: US Dollar USD
35.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 1.51m | 5.58% |
| Armistice Capital LLCas of 31 Dec 2025 | 1.26m | 4.66% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.26m | 4.64% |
| Acadian Asset Management LLCas of 31 Dec 2025 | 1.08m | 3.99% |
| Camber Capital Management LPas of 30 Jun 2025 | 975.00k | 3.59% |
| Columbia Management Investment Advisers LLCas of 31 Dec 2025 | 860.55k | 3.17% |
| DAFNA Capital Management LLCas of 31 Dec 2025 | 827.07k | 3.05% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 665.34k | 2.45% |
| Geode Capital Management LLCas of 31 Dec 2025 | 599.41k | 2.21% |
| Renaissance Technologies LLCas of 31 Dec 2025 | 583.00k | 2.15% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
